Arrowhead to Report Fiscal 2014 Third Quarter Financial Results
– Conference Call Scheduled for Tuesday, August 12, 2014 –
PASADENA, Calif.–(BUSINESS WIRE)–
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical
company developing targeted RNAi therapeutics, today announced that it
will report its financial results for the fiscal 2014 third quarter
ended June 30, 2014, on Tuesday, August 12, 2014, at 4:30 p.m. EDT. To
participate in the conference call, please dial 855-215-6159 (toll free
from the US) or 315-625-6887 (for international callers) and enter
Conference ID 82825377. Investors may also access a live audio webcast
of this conference call on the Company’s website at http://www.arrowheadresearch.com/presentations.
A replay of the webcast will be available approximately two hours after
the conclusion of the call and will remain available for 90 days. An
audio replay will also be available approximately two hours after the
conclusion of the call and will be available for 7 days. The audio
replay can be accessed by dialing 855-859-2056 (toll free from the US),
or 404-537-3406 (for international callers) and entering Conference ID
82825377.
About Arrowhead Research Corporation
Arrowhead Research Corporation is a biopharmaceutical company developing
targeted RNAi therapeutics. The company is leveraging its proprietary
drug delivery technologies to develop targeted drugs based on the RNA
interference mechanism that efficiently silences disease-causing genes.
Arrowhead technologies also enable partners to create peptide-drug
conjugates that specifically home to cell types of interest while
sparing off-target tissues. Arrowhead’s pipeline includes ARC-520 for
chronic hepatitis B virus, ARC-AAT for liver disease associated with
Alpha-1 antitrypsin deficiency, and partner-based programs in obesity
and oncology.
For more information please visit http://www.arrowheadresearch.com,
or follow us on Twitter @ArrowRes.
To be added to the Company’s email list to receive news directly, please
send an email to ir@arrowres.com
Contacts:
Arrowhead Research Corporation
Vince
Anzalone, CFA
626-304-3400
ir@arrowres.com
or
Investor
Relations:
The Trout Group
Lauren Glaser
646-378-2972
ir@arrowres.com
or
Media:
Russo
Partners
Martina Schwarzkopf, Ph.D.
212-845-4292
martina.schwarzkopf@russopartnersllc.com
Source: Arrowhead Research Corporation
News Provided by Acquire Media